Incidence and Factors Associated With the Development and Severity of Oral Mucositis
NCT00575809 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 633
Last updated 2021-07-21
Summary
Our study intends to evaluate prospectively the incidence and severity of oral mucositis in patients undergoing high-dose chemotherapy and hematopoietic stem cell transplantation, as well as to evaluate the potential influence of nutritional-, physical-, and transplant-related factors associated with the development of this complication and its grade of involvement.
Conditions
- Peripheral Blood Stem Cell Transplantation
Interventions
- OTHER
-
Mucositis and nutritional assessments
Mucositis and nutritional assessments before and during the hematopoietic stem cell transplantation
Sponsors & Collaborators
-
South Texas Veterans Health Care System
collaborator FED -
The University of Texas Health Science Center at San Antonio
lead OTHER
Principal Investigators
-
Cesar O Freytes, MD · South Texas Veterans Health Care System
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-05-31
- Primary Completion
- 2021-07-15
- Completion
- 2021-07-15
Countries
- United States
Study Locations
More Related Trials
-
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer
NCT01155609 ·Status: COMPLETED ·Phase: NA
-
Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma
NCT02945878 ·Status: UNKNOWN
-
Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors
NCT01272570 ·Status: COMPLETED
-
Prevention of Oral Mucositis Using Photobiomodulation Therapy
NCT04227340 ·Status: COMPLETED ·Phase: NA
-
Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy
NCT00041665 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Mucositis in Patients Undergoing Antineoplastic Chemotherapy
NCT01036633 ·Status: COMPLETED
-
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NCT06532279 ·Status: RECRUITING ·Phase: PHASE2
-
Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma
NCT00118339 ·Status: COMPLETED ·Phase: NA
-
N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation.
NCT04756622 ·Status: UNKNOWN ·Phase: PHASE3
-
Oral Hygiene Regimen in Patients on HCT
NCT02662374 ·Status: UNKNOWN ·Phase: PHASE4
-
A Trial Assessing Chemo Mouthpiece Device With Best Supportive Care for Symptoms of Chemotherapy-Induced Oral Mucositis
NCT04595838 ·Status: COMPLETED ·Phase: NA
-
Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients
NCT00055380 ·Status: COMPLETED ·Phase: PHASE1
-
Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)?
NCT00431925 ·Status: UNKNOWN
-
A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy
NCT00626639 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
TRIAD Burden of Illness Mucositis Study
NCT00336609 ·Status: UNKNOWN
-
The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck Cancer
NCT02575313 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
NCT00004132 ·Status: COMPLETED ·Phase: PHASE2
-
Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant
NCT00728585 ·Status: WITHDRAWN ·Phase: PHASE2
-
Oral Zinc Therapy for the Prevention of Mucositis
NCT00449592 ·Status: COMPLETED ·Phase: PHASE4
-
Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients
NCT03972527 ·Status: COMPLETED ·Phase: NA
-
Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies
NCT00845819 ·Status: COMPLETED ·Phase: PHASE2
-
Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy
NCT03647527 ·Status: UNKNOWN
-
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
NCT00008398 ·Status: COMPLETED ·Phase: PHASE3
-
A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis
NCT06308328 ·Status: RECRUITING
-
Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment
NCT03228147 ·Status: COMPLETED ·Phase: NA